These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34126617)

  • 1. Extracorporeal Blood Purification in Moderate and Severe COVID-19 Patients: A Prospective Cohort Study.
    Rosalia RA; Ugurov P; Neziri D; Despotovska S; Kostoska E; Veljanovska-Kiridjievska L; Kuzmanov D; Trifunovski A; Popevski D; Villa G; Mitrev Z
    Blood Purif; 2022; 51(3):233-242. PubMed ID: 34126617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Initiation of Extracorporeal Blood Purification Using the AN69ST (oXiris
    Ugurov P; Popevski D; Gramosli T; Neziri D; Vuckova D; Gjorgon M; Stoicovski E; Marinkovic S; Veljanovska-Kiridjievska L; Ignevska K; Mehandziska S; Ambarkova E; Mitrev Z; Rosalia RA
    Braz J Cardiovasc Surg; 2022 Mar; 37(1):35-47. PubMed ID: 33113325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19).
    Asgharpour M; Mehdinezhad H; Bayani M; Zavareh MSH; Hamidi SH; Akbari R; Ghadimi R; Bijani A; Mouodi S
    BMC Nephrol; 2020 Aug; 21(1):356. PubMed ID: 32819292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study.
    Copaescu A; James F; Mouhtouris E; Vogrin S; Smibert OC; Gordon CL; Drewett G; Holmes NE; Trubiano JA
    Front Immunol; 2021; 12():646095. PubMed ID: 33815405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-dimer, CRP, PCT, and IL-6 Levels at Admission to ICU Can Predict In-Hospital Mortality in Patients with COVID-19 Pneumonia.
    Milenkovic M; Hadzibegovic A; Kovac M; Jovanovic B; Stanisavljevic J; Djikic M; Sijan D; Ladjevic N; Palibrk I; Djukanovic M; Velickovic J; Ratkovic S; Brajkovic M; Popadic V; Klasnja S; Toskovic B; Zdravkovic D; Crnokrak B; Markovic O; Bjekic-Macut J; Aleksic A; Petricevic S; Memon L; Milojevic A; Zdravkovic M
    Oxid Med Cell Longev; 2022; 2022():8997709. PubMed ID: 35237386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.
    Liu F; Li L; Xu M; Wu J; Luo D; Zhu Y; Li B; Song X; Zhou X
    J Clin Virol; 2020 Jun; 127():104370. PubMed ID: 32344321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and outcomes of critically ill patients with covid-19 in Sakarya, Turkey: a single centre cohort study.
    Kocayiğit H; Özmen Süner K; Tomak Y; Demir G; Kocayiğit İ; Yaylacı S; Aydemir Y; Köroğlu M; Karabay O; Öztürk MH; Erdem AF
    Turk J Med Sci; 2021 Apr; 51(2):440-447. PubMed ID: 33185365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
    Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
    Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
    [No Abstract]   [Full Text] [Related]  

  • 9. Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia.
    Santa Cruz A; Mendes-Frias A; Oliveira AI; Dias L; Matos AR; Carvalho A; Capela C; Pedrosa J; Castro AG; Silvestre R
    Front Immunol; 2021; 12():613422. PubMed ID: 33679753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in Europe.
    Valverde I; Singh Y; Sanchez-de-Toledo J; Theocharis P; Chikermane A; Di Filippo S; Kuciñska B; Mannarino S; Tamariz-Martel A; Gutierrez-Larraya F; Soda G; Vandekerckhove K; Gonzalez-Barlatay F; McMahon CJ; Marcora S; Napoleone CP; Duong P; Tuo G; Deri A; Nepali G; Ilina M; Ciliberti P; Miller O;
    Circulation; 2021 Jan; 143(1):21-32. PubMed ID: 33166189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inflammatory biomarkers profile of hospitalized patients with COVID-19 and its association with patient's outcome: A single centered study.
    Hachim IY; Hachim MY; Hannawi H; Naeem KB; Salah A; Hannawi S
    PLoS One; 2021; 16(12):e0260537. PubMed ID: 34855832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19.
    Herold T; Jurinovic V; Arnreich C; Lipworth BJ; Hellmuth JC; von Bergwelt-Baildon M; Klein M; Weinberger T
    J Allergy Clin Immunol; 2020 Jul; 146(1):128-136.e4. PubMed ID: 32425269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial.
    Hetzel GR; Schmitz M; Wissing H; Ries W; Schott G; Heering PJ; Isgro F; Kribben A; Himmele R; Grabensee B; Rump LC
    Nephrol Dial Transplant; 2011 Jan; 26(1):232-9. PubMed ID: 20876598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REPORT- Varying pattern of blood gases, ferritin, procalcitonin, C-Reactive protein, interleukin 6 and lactate dehydrogenase in Covid-19 patients suffering from diverse Co-Morbid, suspected cytokine storm and periodic effects of antiviral and steroidal treatments.
    Mahmood Alam J; Asghar SS; Ali H; Mahmood SR; Ansari MA
    Pak J Pharm Sci; 2021 Nov; 34(6):2265-2271. PubMed ID: 35034890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.
    Liu L; Zheng Y; Cai L; Wu W; Tang S; Ding Y; Liu W; Kou G; Xiong Z; Wang S; Zheng S
    Int J Lab Hematol; 2021 Apr; 43(2):329-335. PubMed ID: 33099889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis.
    Huang I; Pranata R; Lim MA; Oehadian A; Alisjahbana B
    Ther Adv Respir Dis; 2020; 14():1753466620937175. PubMed ID: 32615866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The different manifestations of COVID-19 in adults and children: a cohort study in an intensive care unit.
    Girona-Alarcon M; Bobillo-Perez S; Sole-Ribalta A; Hernandez L; Guitart C; Suarez R; Balaguer M; Cambra FJ; Jordan I; ;
    BMC Infect Dis; 2021 Jan; 21(1):87. PubMed ID: 33472588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.
    Zeng Z; Yu H; Chen H; Qi W; Chen L; Chen G; Yan W; Chen T; Ning Q; Han M; Wu D
    Crit Care; 2020 Aug; 24(1):525. PubMed ID: 32854750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and laboratory characteristics of the COVID-19 disease in adult patients.
    Šín R; Kubiska M; Cmorej PC; Váchalová J
    Neuro Endocrinol Lett; 2020 Dec; 41(5):223-230. PubMed ID: 33315336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.